MVP Indeed

The Houston tech company that's helping startups shape their ideas

When it comes to app development, you want experience. Getty

Startups, listen up. Techwave, newly headquartered in Houston, helps startup businesses analyze the demand for their product in the market by providing expert-level MVP application development services.

How, exactly, do they deliver on this? Here's a step by step breakdown:

1. Product design and prototyping
MVP application developers build clickable prototype designs to help startup businesses transform their vision and shape their ideas from a single feature prototype to a high-performance, interactive, and scalable product.

2. IT team augmentation hire
Techwave's industry experienced MVP app developers can augment your existing in-house development team, providing additional resources that enable your team to speed up the process to deliver your product on time.

3. Pilot MVP development
Establish a solution architecture design, implement features, perform integrations, and run QA tests to develop an innovative, high-quality, and reliable MVP mobile or web app that will upscale your business to the next level.

4. Advisory & consulting services
Techwave scales your concept ideas and assesses your budgetary/time constraints to establish a solution that best aligns with your overall vision, providing expert consulting services based on its extensive MVP app development experience.

To learn more about Techwave and see how it could help your startup get a leg up, visit the website.

Trending News

Building Houston

 
 

You can now hop online and invest in this promising cell therapy startup. Photo via Getty Images

A clinical-stage company headquartered in Houston has opened an online funding campaign.

FibroBiologics, which is developing fibroblast cell-based therapeutics for chronic diseases, launched a campaign with equity crowdfunding platform StartEngine. The platform lets anyone — regardless of their net worth or income level — to invest in securities issued by startups.

The funding, according to a press release, will be used to support ongoing operations of Fibrobiologics and advance its clinical programs in multiple sclerosis, degenerative disc disease, wound care, extension of life, and cancer.

"We're excited to partner with StartEngine on this campaign. StartEngine has over 600,000 investors as part of their community and has raised over half a billion dollars for its clients," says FibroBiologics' Founder and CEO Pete O'Heeron, in the release.

"This is an exciting time at FibroBiologics as we continue progressing our clinical pipeline and developing innovative therapies to treat chronic diseases," he continues. "This new funding will fuel our growth in the lab and bring us one step closer to commercialization."

The campaign, launched this week, already has over 100 investors, at the time of publication, and has raised nearly $2 million, according to the page. The minimum investment is set at around $500, and the company's indicated valuation is $252.57 million.

In 2021, FibroBiologics announced its intention of going public. Last year, O'Heeron told InnovationMap on the Houston Innovators Podcast of the company's growth plans as well as the specifics of the technology.

Only two types of cells — stem cells and fibroblasts — can be used in cell therapy for a regenerative treatment, which is when specialists take healthy cells from a patient and inject them into a part of the body that needs it the most. As O'Heeron explains in the podcast, fibroblasts can do it more effectively and cheaper than stem cells.

"(Fibroblasts) can essentially do everything a stem cell can do, only they can do it better," says O'Heeron. "We've done tests in the lab and we've seen them outperform stem cells by a low of 50 percent to a high of about 220 percent on different disease paths."


Trending News